Home
About
Overview
Sharing Data
ORCID
Help
History (133)
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.
Treatment of cancer in sub-Saharan Africa.
Physicians' Beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists.
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
See All 133 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer. Lung Cancer. 2013 Jul; 81(1):138-41.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cell Nucleus
Disease-Free Survival
ErbB Receptors
Female
Humans
Lung Neoplasms
Male
Middle Aged
Predictive Value of Tests
Retrospective Studies
authors with profiles
Ravi Salgia